Bernice Y. Kwong

Multidisciplinary AE management education for EGFR-mutated NSCLC: Mixed-methods QI outcomes.

Michael White, PhD Tariqa Ackbarali, Jason Olivieri, Bernice Y. Kwong et autres

e23368 Background: Anti-EGFR therapies for EGFR-mutated NSCLC have dermatologic and other adverse events (AEs) that benefit from standardized, multidisciplinary management in community practice. Methods: Three-phase mixed-methods quality-improvement initiative. Phase 1 used Premier Network encounter analytics from ~4,400 hospitals/health systems (Jan 2021–Apr 2024) …

us (code pays fourni par la source)

Disparities in supportive care access and financial burden associated with chemotherapy-induced alopecia in women with breast cancer.

Simonetta I. Gaumond, J Lee, Carlos Lange Nava, Lillian Ashleigh Hubbard et autres

e13748 Background: Chemotherapy-induced alopecia (CIA) remains one of the most visible and psychologically distressing toxicities of breast cancer therapy. Despite its high prevalence and impact on treatment experience, CIA management is inconsistently integrated into oncology supportive care pathways, and access to mitigation …

us (code pays fourni par la source)

Cutaneous Toxicities of Small Molecules in Targeted Cancer Therapy Part I – Mechanisms of Toxicity

Ian R. Nykaza, Bernice Y. Kwong, Allison Gordon

us (code pays fourni par la source)

Cutaneous Toxicities of Small Molecules in Targeted Cancer Therapy Part II – Approach to Management and Treatment

Ian R. Nykaza, Bernice Y. Kwong, Allison Gordon

us (code pays fourni par la source)

New Diagnostics and Management for Trichodysplasia Spinulosa

Nicole M. Urman, Ryanne A. Brown, Kerri E. Rieger, Roberto A. Novoa et autres

This case report describes a patient with a history of refractory acute myeloid leukemia who presented with white, spiny hyperkeratotic papules on his face and neck, and was subsequently diagnosed with trichodysplasia spinulosa.

us (code pays fourni par la source)

CTNI-77. Phase 1 study of tumor treating fields concurrent with 5 day hypofractionated stereotactic radiosurgery with concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma..

Scott Gerard Soltys, Bernice Y. Kwong, Chirag R. Patel, Camellia Djebroun et autres

Abstract BACKGROUND Preclinical data suggest greater efficacy of radiotherapy when combined with Tumor Treating Fields (TTFs). Building upon our previous phase I trial of 5-fraction stereotactic radiosurgery (SRS), we sought to determine the safety of adding TTFs concurrent with 5-day SRS with …

us (code pays fourni par la source)

62532 Prevalence of nutritional deficiencies in patients with cutaneous graft-versus-host disease

Konnie Guo, Bernice Y. Kwong

Efficacy of hedgehog pathway inhibitors as adjuvant in treating steroid-refractory sclerodermatous chronic graft-versus-host disease

Andres Mendez-Hernandez, Ridhi Gupta, Sally Arai, Robert Lowsky et autres

us (code pays fourni par la source)

Diagnostic stewardship and dermatology consultation in cellulitis management: a systematic literature review and meta-analysis

Vivian K. Lin, Gustavo Yano Callado, Isabele Pardo, Maria Celidonio Gutfreund et autres

br, us (code pays fourni par la source)

Management of human epidermal growth factor receptor inhibitors‐related acneiform rash: A position paper based on the first Europe/ USA Delphi consensus process

Zoé Apalla, Azael Freites‐Martínez, Katerina Grafanaki, Ariadna Ortiz‐Brugués et autres

BACKGROUND: There is a need for unified guidance in the management of acneiform rash induced by epidermal growth factor receptor inhibitors (EGFRi) among dermatologists. OBJECTIVE: To establish unified international guidelines for the management of acneiform rash caused by EGFR inhibitors, based on …

gr, es, fr, it, us, nl, fi, ca, il, bg, ar, ph, ch, al, de (code pays fourni par la source)

Phase II Trial of Regorafenib and Oral Methotrexate in Previously Treated Advanced KRAS-Mutant NSCLC

Jacqueline V. Aredo, Heather A. Wakelee, Kavitha J. Ramchandran, Joel W. Neal et autres

Introduction There are no standard targeted treatment options for advanced KRAS -mutant NSCLC beyond KRAS G12C inhibitors. A computational model identified regorafenib and low-dose methotrexate as synergistic in preclinical models of KRAS -mutant NSCLC. This study evaluated the efficacy and safety of …

us, in (code pays fourni par la source)

Diagnostic stewardship and dermatology consultation in cellulitis management: a systematic literature review and meta-analysis

Vivian K. Lin, Gustavo Yano Callado, Isabele Pardo, Maria Gutfreud et autres

br, us (code pays fourni par la source)